Context Therapeutics has dosed the first subject in the Phase I trial of CTIM-76, targeting claudin 6 (CLDN6)-positive ...
The humanised trispecific antibody is undergoing Phase I trials in the US and China in subjects with relapsed or refractory ...
(Photo Credit: iStock/Getty Images) CD4 cells and CD8 cells are named after proteins on their surface: CD4 cells have a protein called cluster of differentiation 4 (CD4), while CD8 cells have a ...
Investigators at Mass General Brigham in Massachusetts, US, have reported outcomes from a study of a new immunotherapy for ...